Literature DB >> 2196572

Isolation of mutants of human immunodeficiency virus protease based on the toxicity of the enzyme in Escherichia coli.

E Z Baum1, G A Bebernitz, Y Gluzman.   

Abstract

The protease encoded by the pol gene of human immunodeficiency virus was expressed in Escherichia coli and found to be toxic to strain BL21(DE3). This toxicity provided a convenient selection for isolating mutants of the protease that are nontoxic and enzymatically inactive. This strong correlation between functional protease and toxicity resulted in rapid identification of several protease mutations, including mutations that exhibit temperature sensitivity. A total of 24 missense mutations and 7 nonsense mutations were identified. The described selection procedure may have wider applications for isolating mutants of other eukaryotic proteins that exhibit a toxic phenotype in E. coli.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2196572      PMCID: PMC54367          DOI: 10.1073/pnas.87.14.5573

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  24 in total

1.  Mutational specificity of a conditional Escherichia coli mutator, mutD5.

Authors:  R G Fowler; G E Degnen; E C Cox
Journal:  Mol Gen Genet       Date:  1974

2.  T7 lysozyme inhibits transcription by T7 RNA polymerase.

Authors:  B A Moffatt; F W Studier
Journal:  Cell       Date:  1987-04-24       Impact factor: 41.582

3.  Human immunodeficiency virus has an aspartic-type protease that can be inhibited by pepstatin A.

Authors:  S Seelmeier; H Schmidt; V Turk; K von der Helm
Journal:  Proc Natl Acad Sci U S A       Date:  1988-09       Impact factor: 11.205

4.  Human immunodeficiency virus protease expressed in Escherichia coli exhibits autoprocessing and specific maturation of the gag precursor.

Authors:  C Debouck; J G Gorniak; J E Strickler; T D Meek; B W Metcalf; M Rosenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

5.  A structural model for the retroviral proteases.

Authors:  L H Pearl; W R Taylor
Journal:  Nature       Date:  1987 Sep 24-30       Impact factor: 49.962

6.  An 11-kDa form of human immunodeficiency virus protease expressed in Escherichia coli is sufficient for enzymatic activity.

Authors:  M C Graves; J J Lim; E P Heimer; R A Kramer
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

7.  Active human immunodeficiency virus protease is required for viral infectivity.

Authors:  N E Kohl; E A Emini; W A Schleif; L J Davis; J C Heimbach; R A Dixon; E M Scolnick; I S Sigal
Journal:  Proc Natl Acad Sci U S A       Date:  1988-07       Impact factor: 11.205

8.  X-ray analysis of HIV-1 proteinase at 2.7 A resolution confirms structural homology among retroviral enzymes.

Authors:  R Lapatto; T Blundell; A Hemmings; J Overington; A Wilderspin; S Wood; J R Merson; P J Whittle; D E Danley; K F Geoghegan
Journal:  Nature       Date:  1989-11-16       Impact factor: 49.962

9.  Expression and processing of the AIDS virus reverse transcriptase in Escherichia coli.

Authors:  W G Farmerie; D D Loeb; N C Casavant; C A Hutchison; M H Edgell; R Swanstrom
Journal:  Science       Date:  1987-04-17       Impact factor: 47.728

10.  Partial purification and substrate analysis of bacterially expressed HIV protease by means of monoclonal antibody.

Authors:  J Hansen; S Billich; T Schulze; S Sukrow; K Moelling
Journal:  EMBO J       Date:  1988-06       Impact factor: 11.598

View more
  16 in total

1.  Human immunodeficiency virus type 1 Gag proteins are processed in two cellular compartments.

Authors:  A H Kaplan; R Swanstrom
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-15       Impact factor: 11.205

2.  Diversification and specialization of HIV protease function during in vitro evolution.

Authors:  Taryn L O'Loughlin; Dina N Greene; Ichiro Matsumura
Journal:  Mol Biol Evol       Date:  2006-01-19       Impact factor: 16.240

Review 3.  Expression of virus-encoded proteinases: functional and structural similarities with cellular enzymes.

Authors:  W G Dougherty; B L Semler
Journal:  Microbiol Rev       Date:  1993-12

4.  Human rhinovirus 2A proteinase mutant and its second-site revertants.

Authors:  M Luderer-Gmach; H D Liebig; W Sommergruber; T Voss; F Fessl; T Skern; E Kuechler
Journal:  Biochem J       Date:  1996-08-15       Impact factor: 3.857

5.  HIV-I protease. Cloning, expression, and purification.

Authors:  N I Dergousova; A M Volynskaya; L D Rumsh
Journal:  Appl Biochem Biotechnol       Date:  1996 Oct-Nov       Impact factor: 2.926

6.  Expression and analysis of the human cytomegalovirus UL80-encoded protease: identification of autoproteolytic sites.

Authors:  E Z Baum; G A Bebernitz; J D Hulmes; V P Muzithras; T R Jones; Y Gluzman
Journal:  J Virol       Date:  1993-01       Impact factor: 5.103

7.  Expression of Chinese hamster cAMP-dependent protein kinase in Escherichia coli results in growth inhibition of bacterial cells: a model system for the rapid screening of mutant type I regulatory subunits.

Authors:  M E Gosse; A Padmanabhan; R D Fleischmann; M M Gottesman
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-01       Impact factor: 11.205

8.  Cell-based fluorescence assay for human immunodeficiency virus type 1 protease activity.

Authors:  K Lindsten; T Uhlíková; J Konvalinka; M G Masucci; N P Dantuma
Journal:  Antimicrob Agents Chemother       Date:  2001-09       Impact factor: 5.191

9.  beta-Galactosidase containing a human immunodeficiency virus protease cleavage site is cleaved and inactivated by human immunodeficiency virus protease.

Authors:  E Z Baum; G A Bebernitz; Y Gluzman
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

10.  Selective killing of human immunodeficiency virus infected cells by non-nucleoside reverse transcriptase inhibitor-induced activation of HIV protease.

Authors:  Dirk Jochmans; Maria Anders; Inge Keuleers; Liesbeth Smeulders; Hans-Georg Kräusslich; Günter Kraus; Barbara Müller
Journal:  Retrovirology       Date:  2010-10-15       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.